Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | (+)-schisandrin B | multiple interactions | EXP | | 6480464 | schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of YOD1 mRNA] | CTD | PMID:31150632 | (1->4)-beta-D-glucan | multiple interactions | ISO | Yod1 (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of YOD1 mRNA | CTD | PMID:36331819 | 1,2-dimethylhydrazine | decreases expression | ISO | Yod1 (Mus musculus) | 6480464 | 1 and 2-Dimethylhydrazine results in decreased expression of YOD1 mRNA | CTD | PMID:22206623 | 17beta-estradiol | affects expression | EXP | | 6480464 | Estradiol affects the expression of YOD1 mRNA | CTD | PMID:32145629 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | YOD1 (Homo sapiens) | 6480464 | Tetrachlorodibenzodioxin affects the expression of YOD1 mRNA | CTD | PMID:22298810 | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of YOD1 mRNA | CTD | PMID:32109520 and PMID:33387578 | 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | Yod1 (Mus musculus) | 6480464 | [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of YOD1 mRNA | CTD | PMID:25975270 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Yod1 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of YOD1 mRNA | CTD | PMID:21570461 | 2-hydroxypropanoic acid | decreases expression | ISO | YOD1 (Homo sapiens) | 6480464 | Lactic Acid results in decreased expression of YOD1 mRNA | CTD | PMID:30851411 | 3,4-methylenedioxymethamphetamine | increases expression | ISO | Yod1 (Mus musculus) | 6480464 | N-Methyl-3 and 4-methylenedioxyamphetamine results in increased expression of YOD1 mRNA | CTD | PMID:20188158 | aflatoxin B1 | increases expression | ISO | Yod1 (Mus musculus) | 6480464 | Aflatoxin B1 results in increased expression of YOD1 mRNA | CTD | PMID:19770486 | aflatoxin M1 | decreases expression | ISO | YOD1 (Homo sapiens) | 6480464 | Aflatoxin M1 results in decreased expression of YOD1 mRNA | CTD | PMID:30928695 | aristolochic acid A | decreases expression | ISO | YOD1 (Homo sapiens) | 6480464 | aristolochic acid I results in decreased expression of YOD1 mRNA | CTD | PMID:33212167 | azoxystrobin | multiple interactions | EXP | | 6480464 | [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased methylation of YOD1 gene | CTD | PMID:33854195 | benzo[a]pyrene | increases expression | ISO | YOD1 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in increased expression of YOD1 mRNA | CTD | PMID:20064835 | benzo[a]pyrene | decreases methylation | ISO | YOD1 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in decreased methylation of YOD1 promoter | CTD | PMID:27901495 | benzo[a]pyrene diol epoxide I | increases expression | ISO | YOD1 (Homo sapiens) | 6480464 | 7 more ... | CTD | PMID:19150397 and PMID:20382639 | bisphenol A | decreases expression | ISO | YOD1 (Homo sapiens) | 6480464 | bisphenol A results in decreased expression of YOD1 mRNA | CTD | PMID:20678512 | bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of YOD1 mRNA | CTD | PMID:32145629 | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of YOD1 mRNA | CTD | PMID:30816183 and PMID:32528016 | bisphenol A | affects expression | EXP | | 6480464 | bisphenol A affects the expression of YOD1 mRNA | CTD | PMID:25181051 | chlorpyrifos | multiple interactions | EXP | | 6480464 | [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased methylation of YOD1 gene | CTD | PMID:33854195 | chlorpyrifos | decreases expression | ISO | Yod1 (Mus musculus) | 6480464 | Chlorpyrifos results in decreased expression of YOD1 mRNA | CTD | PMID:37019170 | copper atom | multiple interactions | ISO | YOD1 (Homo sapiens) | 6480464 | [NSC 689534 binds to Copper] which results in increased expression of YOD1 mRNA | CTD | PMID:20971185 | copper(0) | multiple interactions | ISO | YOD1 (Homo sapiens) | 6480464 | [NSC 689534 binds to Copper] which results in increased expression of YOD1 mRNA | CTD | PMID:20971185 | cyclosporin A | increases expression | ISO | YOD1 (Homo sapiens) | 6480464 | Cyclosporine results in increased expression of YOD1 mRNA | CTD | PMID:25562108 | dioxygen | increases expression | ISO | Yod1 (Mus musculus) | 6480464 | Oxygen deficiency results in increased expression of YOD1 mRNA | CTD | PMID:22629407 | dioxygen | multiple interactions | ISO | Yod1 (Mus musculus) | 6480464 | Oxygen inhibits the reaction [Oxygen deficiency results in increased expression of YOD1 mRNA] | CTD | PMID:22629407 | doxorubicin | affects expression | ISO | YOD1 (Homo sapiens) | 6480464 | Doxorubicin affects the expression of YOD1 mRNA | CTD | PMID:29803840 | endosulfan | increases expression | EXP | | 6480464 | Endosulfan results in increased expression of YOD1 mRNA | CTD | PMID:29391264 | epoxiconazole | decreases expression | ISO | Yod1 (Mus musculus) | 6480464 | epoxiconazole results in decreased expression of YOD1 mRNA | CTD | PMID:35436446 | flutamide | increases expression | EXP | | 6480464 | Flutamide results in increased expression of YOD1 mRNA | CTD | PMID:24793618 | folic acid | decreases expression | ISO | Yod1 (Mus musculus) | 6480464 | Folic Acid results in decreased expression of YOD1 mRNA | CTD | PMID:25629700 | FR900359 | increases phosphorylation | ISO | YOD1 (Homo sapiens) | 6480464 | FR900359 results in increased phosphorylation of YOD1 protein | CTD | PMID:37730182 | gentamycin | increases expression | EXP | | 6480464 | Gentamicins results in increased expression of YOD1 mRNA | CTD | PMID:33387578 | glyphosate | multiple interactions | EXP | | 6480464 | [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased methylation of YOD1 gene | CTD | PMID:33854195 | gold atom | decreases expression | ISO | YOD1 (Homo sapiens) | 6480464 | Gold results in decreased expression of YOD1 mRNA | CTD | PMID:25523186 | gold(0) | decreases expression | ISO | YOD1 (Homo sapiens) | 6480464 | Gold results in decreased expression of YOD1 mRNA | CTD | PMID:25523186 | imidacloprid | multiple interactions | EXP | | 6480464 | [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased methylation of YOD1 gene | CTD | PMID:33854195 | indometacin | decreases expression | ISO | YOD1 (Homo sapiens) | 6480464 | Indomethacin results in decreased expression of YOD1 mRNA | CTD | PMID:16984733 | iron dichloride | increases expression | ISO | YOD1 (Homo sapiens) | 6480464 | ferrous chloride results in increased expression of YOD1 mRNA | CTD | PMID:35984750 | lead(0) | affects methylation | ISO | YOD1 (Homo sapiens) | 6480464 | Lead affects the methylation of YOD1 gene | CTD | PMID:31636367 | melphalan | increases expression | ISO | YOD1 (Homo sapiens) | 6480464 | Melphalan results in increased expression of YOD1 mRNA | CTD | PMID:22363485 | methylisothiazolinone | increases expression | ISO | YOD1 (Homo sapiens) | 6480464 | 2-methyl-4-isothiazolin-3-one results in increased expression of YOD1 mRNA | CTD | PMID:31629900 | paracetamol | affects expression | ISO | Yod1 (Mus musculus) | 6480464 | Acetaminophen affects the expression of YOD1 mRNA | CTD | PMID:17562736 | paracetamol | increases expression | EXP | | 6480464 | Acetaminophen results in increased expression of YOD1 mRNA | CTD | PMID:33387578 | pentachlorophenol | increases expression | ISO | Yod1 (Mus musculus) | 6480464 | Pentachlorophenol results in increased expression of YOD1 mRNA | CTD | PMID:23892564 | perfluorooctane-1-sulfonic acid | decreases expression | ISO | YOD1 (Homo sapiens) | 6480464 | perfluorooctane sulfonic acid results in decreased expression of YOD1 mRNA | CTD | PMID:27153767 | perfluorooctane-1-sulfonic acid | multiple interactions | ISO | Yod1 (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of YOD1 mRNA and [perfluorooctane sulfonic acid co-treated with Pectins] results in decreased expression of YOD1 mRNA | CTD | PMID:36331819 | perfluorooctanoic acid | increases expression | ISO | YOD1 (Homo sapiens) | 6480464 | perfluorooctanoic acid results in increased expression of YOD1 mRNA | CTD | PMID:23978341 | phenobarbital | increases expression | ISO | Yod1 (Mus musculus) | 6480464 | Phenobarbital results in increased expression of YOD1 mRNA | CTD | PMID:19270015 | pirinixic acid | multiple interactions | ISO | Yod1 (Mus musculus) | 6480464 | [pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of YOD1 mRNA | CTD | PMID:19710929 | rac-lactic acid | decreases expression | ISO | YOD1 (Homo sapiens) | 6480464 | Lactic Acid results in decreased expression of YOD1 mRNA | CTD | PMID:30851411 | raloxifene | multiple interactions | ISO | Yod1 (Mus musculus) | 6480464 | [SOD1 protein mutant form affects the susceptibility to Raloxifene Hydrochloride] which results in increased expression of YOD1 mRNA | CTD | PMID:33269387 | raloxifene | increases expression | ISO | Yod1 (Mus musculus) | 6480464 | Raloxifene Hydrochloride results in increased expression of YOD1 mRNA | CTD | PMID:33269387 | sodium dodecyl sulfate | increases expression | ISO | YOD1 (Homo sapiens) | 6480464 | Sodium Dodecyl Sulfate results in increased expression of YOD1 mRNA | CTD | PMID:31734321 | tetrachloromethane | multiple interactions | EXP | | 6480464 | schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of YOD1 mRNA] | CTD | PMID:31150632 | tetrachloromethane | increases expression | ISO | Yod1 (Mus musculus) | 6480464 | Carbon Tetrachloride results in increased expression of YOD1 mRNA | CTD | PMID:31919559 | tetrachloromethane | increases expression | EXP | | 6480464 | Carbon Tetrachloride results in increased expression of YOD1 mRNA | CTD | PMID:31150632 | thiabendazole | multiple interactions | EXP | | 6480464 | [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased methylation of YOD1 gene | CTD | PMID:33854195 | thioacetamide | increases expression | EXP | | 6480464 | Thioacetamide results in increased expression of YOD1 mRNA | CTD | PMID:34492290 | titanium dioxide | decreases expression | ISO | Yod1 (Mus musculus) | 6480464 | titanium dioxide results in decreased expression of YOD1 mRNA | CTD | PMID:29264374 | trichloroethene | increases expression | EXP | | 6480464 | Trichloroethylene results in increased expression of YOD1 mRNA | CTD | PMID:33387578 | trichostatin A | decreases expression | ISO | YOD1 (Homo sapiens) | 6480464 | trichostatin A results in decreased expression of YOD1 mRNA | CTD | PMID:24935251 | urethane | increases expression | ISO | YOD1 (Homo sapiens) | 6480464 | Urethane results in increased expression of YOD1 mRNA | CTD | PMID:28818685 | valproic acid | affects expression | ISO | Yod1 (Mus musculus) | 6480464 | Valproic Acid affects the expression of YOD1 mRNA | CTD | PMID:17963808 | valproic acid | decreases expression | ISO | YOD1 (Homo sapiens) | 6480464 | Valproic Acid results in decreased expression of YOD1 mRNA | CTD | PMID:23179753 and PMID:27188386 | |